HR 1 brings Medicaid work requirements and narrower immigrant eligibility by January 2027, and CBO projects 10 million more uninsured by 2034.
Commentary|Articles|September 17, 2025
Letters From White House Could Encourage Some Compliance With Most-Favored-Nation Executive Order, Broad Agreements Unlikely: Q&A With Kathy Oubre, MS
Author(s)Julia Bonavitacola, Kathy Oubre, MS
New demands to follow the most favored nation executive order could lead to some compliance but it is unknown just how effective they will be across all health care.
Advertisement
Advertisement
In the second part of her Q&A, Kathy Oubre, MS, discusses the recent updates surrounding the most favored nation (MFN) executive order, including how the discussion of tariffs might play into drug pricing and the recent letters that President Donald Trump sent to pharmaceutical companies in July to demand more swift action on the executive order.
Related to this article
New non-CF bronchiectasis in Medicare is tied to high health care use and $8998 PPPM FFS spending; prevalence is highest in older women.
Medicare drug price negotiations lowered out-of-pocket costs for some beneficiaries, but those reaching the annual Part D cap saw no direct savings.
Genetic analysis finds 125 loci shared by insomnia and CRP, with Mendelian randomization favoring an effect from insomnia liability to inflammation.
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
Alice Hall-Partyka, JD, a partner at Crowell & Moring explains the lawsuits challenging CMS' Medicaid rule on pediatric gender care and its legal weak points.
Siva Mohan, MD, explains how drug costs drive silent nonadherence, PA burden, and biosimilar hesitancy, and what payers can do about it.
Proinflammatory diets were tied to higher mortality in MASLD and MetALD, whereas antioxidant-rich diets tracked with better survival.
Advertisement
Advertisement